Enanta Pharmaceuticals

Enanta's RSV antiviral reduces viral load in phase 2 pediatric study
Fierce Biotech
Mon, 12/9/24 - 11:03 am
Enanta Pharmaceuticals
RSV
antivirals
clinical trials
pediatric
Enanta sues Pfizer for infringement on Paxlovid, citing a patent it was granted a week ago
Fierce Pharma
Wed, 06/22/22 - 10:52 am
Enanta Pharmaceuticals
Pfizer
Paxlovid
patents legal
Enanta sinks to multiyear low as phase 2b RSV trial flames out
Fierce Biotech
Thu, 05/19/22 - 10:45 am
Enanta Pharmaceuticals
RSV
clinical trials
EDP-938
Enanta Pharmaceuticals' Q4 Results Pulled Down by AbbVie's Sinking HCV Sales
Motley Fool
Fri, 11/22/19 - 10:04 am
Enanta Pharmaceuticals
earnings
AbbVie
Mavyret
hepatitis C
Enanta's lung infection therapy succeeds in mid-stage trial
Reuters
Fri, 06/14/19 - 06:28 pm
Enanta Pharmaceuticals
RSV
clinical trials
EDP-938
This Small Biotech Is Building on a Surprising Success
Motley Fool
Wed, 04/25/18 - 09:32 am
AbbVie
Mavyret
Enanta Pharmaceuticals
glecaprevir
hepatitis C
New drug approval is a win for the Bay State's horse in the hepatitis C race
Bizjournals.com
Tue, 07/28/15 - 12:34 pm
Enanta Pharmaceuticals
AbbVie
Technivie
hepatitis C
19 Lesser-Known Biotech Stocks With Robust Drug Pipelines
Yahoo/Benzinga
Wed, 12/31/14 - 10:37 am
biotech
Threshold Pharmaceuticals
Acceleron
Spectrum Pharmaceuticals
Ultragenyx
Argos Therapeutics
OncoMed
Peregrine Pharmaceuticals
Incyte
Calithera
Array Biopharma
Theravance
Puma Biotechnology
CTI BioPharma
Orexigen
Enanta Pharmaceuticals
Sucampo
Exelixis
Cubist Pharmaceuticals
United Therapeutics
Enanta Pharmaceuticals beats 4Q profit forecasts
Yahoo/AP
Mon, 11/24/14 - 10:19 am
Enanta Pharmaceuticals
earnings
Novartis drops out of hep C race, punting a $440M Enanta pact
Fierce Biotech
Wed, 10/1/14 - 09:19 am
Novartis
hepatitis C
Enanta Pharmaceuticals
EDP-239
alisporivir
Is This Gilead's Worst Nightmare?
Motley Fool
Tue, 06/17/14 - 07:00 pm
Gilead Sciences
Sovaldi
hepatitis C
Enanta Pharmaceuticals
AbbVie
Enanta notes AbbVie granted FDA priority review for Hep C combo regimen
Yahoo/Fly on the Wall
Fri, 06/13/14 - 06:44 pm
AbbVie
Enanta Pharmaceuticals
FDA
hepatitis C
ABT-450
AbbVie Submits New Drug Application to U.S. FDA for its Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Hepatitis C
Yahoo
Tue, 04/22/14 - 09:48 am
hepatitis C
FDA
Enanta Pharmaceuticals
ABT-450
AbbVie
Big Pharma Ramps Up Hep C Strategies
Yahoo/Investors Business Daily
Wed, 03/19/14 - 07:22 pm
hepatitis C
Sovaldi
Gilead Sciences
daclatasvir
Bristol-Myers Squibb
AbbVie
Enanta Pharmaceuticals
[video]This Small Biotech Will Profit From the Hep C Drug Race
Motley Fool
Fri, 03/14/14 - 08:41 am
biotech
Enanta Pharmaceuticals
hepatitis C
Gilead Sciences
AbbVie
AbbVie's Challenge to Gilead in Hepatitis C Therapies
Motley Fool
Tue, 02/4/14 - 07:00 pm
AbbVie
Gilead Sciences
Sovaldi
hepatitis C
Enanta Pharmaceuticals
ABT-450
This Week in Biotech: Let's Get Clinical!
Motley Fool
Sun, 02/2/14 - 11:30 am
AbbVie
Enanta Pharmaceuticals
ABT-450
hepatitis C
Medivation
Xtandi
prostate cancer
Astellas
Geron
imetelstat
PSMA-ADC
Progenics Pharmaceuticals
Idenix
AbbVie Headed to FDA, Clash With Gilead Set
Motley Fool
Sat, 02/1/14 - 10:49 am
AbbVie
Gilead Sciences
ABT-450
hepatitis
hepatitis C
Enanta Pharmaceuticals
Pulse of J.P. Morgan 2014: Interviews with 17 biopharma execs
Fierce Biotech
Fri, 01/17/14 - 05:54 pm
JPMHC 2014
Algeta
Macrogenics
Xencor
Acetylon
Enanta Pharmaceuticals
Clinigen
Iroko Pharmaceuticals
Protalix BioTherapeutics
Ambrx
Roche
Sialix
Verastem
pRED
Cubist Pharmaceuticals
Celgene
Otonomy
Lumena Pharmaceuticals
AbbVie's second PhIII hep C study confirms cocktail's promise
Fierce Biotech
Tue, 12/10/13 - 10:49 am
hepatitis C
Enanta Pharmaceuticals
ABT-450
AbbVie

Pages